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Abstract The purpose of this study was to adapt various
staining methods for the detection of microdamage in human
bone, while preserving tetracycline labels. We describe two
staining methods using calcein green and xylenol orange, first
developed in ewe bone samples and validated in human tra-
becular bone samples. In ewe bones, we found that calcein
green at 0.5 mM concentration diluted in 100% ethanol as
well as xylenol orange at 5 mM were the most adequate flu-
orochromes both to detect microdamage and preserve the
double tetracycline labeling. These results were verified in
human trabecular bone (iliac crest for the tetracycline label,
and vertebral bone for the double labeling). Results obtained
in human bone samples were identical to those in ewes, so this
combination of fluorochromes is now used in our laboratory.
Keywords Microdamage  Fluorescent labels  Ewe iliac
crest  Human trabecular bone
Introduction
Loading of bone induces in vivo linear and diffuse
microdamage [1–10]. The propensity of bone to form linear
and diffuse damage varies with age and the two forms of
microdamage have different effects on the mechanical prop-
erties of bone and influence skeletal fragility [11–14]. Mi-
crodamage has been largely studied in compact bone [13, 15–
22] but less in human trabecular bone [5, 23–28]. To date, two
main standard methods to stain bone for microdamage
detection have been described: (1) the basic fuchsin bulk
staining used to detect microdamage generated in vivo [2, 6,
19, 25, 29, 30], and (2) the use of fluorescent chelating agents
[16, 17, 19, 31, 32]. In addition to distinguishing fully-stained
microcracks generated in vivo from partially-stained or arti-
factual-stained cracks due to cutting and/or machining, one of
the challenges is to identify and quantify microdamage in
human trabecular bone without washing previous labels used
for histomorphometry and qualitative bone histology.
The aims of this study were to develop a methodological
approach, based on previous work [2, 3, 6, 16, 17, 19, 29,
31], to accurately identify microdamage in trabecular bone
without erasing fluorescent labels such as tetracycline. This
approach has also made it possible to distinguish pre-
existing true from artifactual microdamage and damage
from mechanical testing. We describe here a double
labeling method using two different fluorochromes that was
developed on ewe bone samples and then validated on
human trabecular bone samples.
Materials and methods
The methods were developed in ewe bone and then applied
to human trabecular bone.
Preparation of ewe bone
Fifty transiliac bone biopsies were obtained after tetracy-
cline labeling from ewes under local anesthesia, with a
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7.5-mm internal diameter trephine, 2 cm behind the
anterosuperior iliac spine and 2 cm below the iliac crest
edge (Fig. 1) [33]. To rule out artifactual microdamage,
bone samples needed to be stained before and after cutting
the sections. Biopsies were then separated into two parts.
One half served as a control to observe double labeling on
unstained sections, and the other half served for the fluo-
rochrome tests.
To quantify the correct concentration, dilution and time
limit for detecting both microdamage and labels, 34 half-
biopsies were bulk-stained separately at room temperature
with the following fluorochromes (Table 1; Fig. 2): basic
fuchsin1 (BF), n = 1; fluorescein,2 n = 12; calcein blue,3
n = 4; alizarin complexone,4 n = 2; calcein green,5 n = 6;
and xylenol orange,6 n = 9. All tests were performed either
in ethanol or a water-based solution and different concen-
trations and duration of bulk staining were tested for each
fluorochrome (Table 1). To verify that fluorochrome
staining did not alter classical histological stains, a few
supplementary sections were cut for Goldner’s trichrome,
Solochrome cyanin R, May-Gru¨nwald-Giemsa and
Toluidine blue [34].
To assess the double labeling study, 16 half-biopsies
were processed (Table 2). Two successive bulk stainings
were performed at room temperature on the same sample,
combining basic fuchsin, fluorescein, xylenol orange and
calcein green (Table 2). We considered basic fuchsin as the
staining reference. For this, bone samples were bulk-
stained in 1% basic fuchsin in 70, 80, 90, and 100% ethanol
under vacuum at 15–20 mmHg for 4 h each. After staining,
core samples were fixed in 70% ethanol, rinsed in 100%
ethanol and embedded in methyl methacrylate [6, 34, 35].
The best staining results obtained on ewes were used on
human trabecular bone.
Preparation of human trabecular bone
Transiliac bone biopsies
Fifty postmenopausal osteoporotic women who had been on
bisphosphonates were recruited from the outpatient clinic.
Transiliac bone biopsies were performed after all patients
were double-labeled with demethylchlortetracycline. Theses
samples were used to verify and validate the effect of flu-
orochromes on double tetracycline labels [36].
Vertebral bone cores
Six human vertebrae (3L2 and 3L4) obtained from recently
deceased donors were bulk-stained for 11 days at room
temperature in 5 mM xylenol orange based in 70% ethanol
[37, 38]. After staining, a 8.25-mm diameter cylindrical
trabecular specimen was removed using a diamond-tipped
coring tool. To detect the induced microdamage, trabecular
cores were bulk-stained for 2 days in 0.5 mM green calcein
based in 100% ethanol and thereafter embedded in methyl
methacrylate. Theses samples were used to verify the
double labeling of fluorochromes for the detection of
microdamage.
Preparation for histomorphometry
All undecalcified bones were cut along the long axis at very
low speed using a heavy-duty microtome (Polycut E, Leica
Microsystems, Wetzlar, Germany) equipped with tungsten
carbide knives to obtain at least three non-contiguous,
parallel, 100 ± 5 lm sections for detection of microcracks.
Several consecutive 8-lm sections were cut to measure
bone trabecular volume and area, and also to be used
afterwards to test the classical histological staining proce-
dures. Sections were then mounted between microscope
slides and cover glasses with a mounting medium (Neo-
Entellan, Merck, Germany).
Microdamage detection and analysis
Microdamage was detected by optical microscopy (Carl
Zeiss, Germany) under fluorescent light at 9200
Fig. 1 Preparation of transiliac
bone biopsies from ewes
1 B660-30 JT Baker, Phillipsburg, NJ, USA.
2 F 6377 Sigma Chemical Co., St Louis, MO, USA.
3 M1255 Sigma.
4 A3882 Sigma.
5 C 0875 Sigma.
6 398187 Sigma.
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magnification and using morphometry software (Bone
Morpho; Explora Nova, La Rochelle, France). Microdam-
age was observed using several specific filters at excitation/
emission wavelengths of 440/610 nm (Filter set #207 from
Zeiss), 495/520 nm (Filter set #098 from Zeiss) and
390/590 nm (Filter set #189 from Zeiss) (Table 3). To
avoid artifactual cutting damage, the region of measure-
ment was located \ 0.8 mm from any cutting edge.
Microdamage was categorized and quantified as linear
microcracks or diffuse damage. Outcome assessments
included the number of linear cracks (Cr.N, #), the number
of diffuse damage areas (Dx.N, #), the linear crack density,
Table 1 Staining tests performed (n = 34) with chelating agents including concentration, bulk staining time and final result for the detection of
both microdamage and labels
Agent Dilution Concentration Time Results Final
results
Crack
stained
Crack
measurable
Visibility of
previous label
Basic fuchsin Ethanol 1% 24 h ?? ?? ? ?
Fluorescein Ringer’s solution 12% 24 h ??? ? --- -
12% 12 h ? --- --- ---
60 min ? --- --- ---
30 min ? --- --- ---
6% 24 h ? --- --- ---
3% 24 h ? --- --- ---
Ethanol 100% 12% 24 h ??? ? --- ---
12% 12 h ? - --- ---
60 min ? - --- ---
30 min ? - --- ---
6% 24 h ? - --- ---
3% 24 h ? - --- ---
Calcein blue Water 10 mM 12 h - - ? ?
0.1 mM 2 h ?? ?? - -
Ethanol 100% 10 mM 12 h - - ? ?
0.1 mM 2 h ?? ?? - -
Alizarin complexone Water 0.5 mM 2 h ??? ??? ? ?
Ethanol 100% 0.5 mM 2 h ??? ??? ?? ??
Calcein green Tris HCl 0.5 M 0.5 mM 12 h - - - -
2 h ??? ??? ? ??
Water 0.5 mM 12 h - - - -
2 h ??? ??? ? ??
Ethanol 100% 0.5 mM 12 h - - - -
2 h ??? ??? ??? ???
Xylenol orange Tris HCl 0.5 M 1% 2 h - - - -
Water 5 mM 12 h - - - -
2 h ??? ??? ? ??
0.5 mM 12 h - - ? -
2 h - - ? -
Ethanol 100% 5 mM 12 h - - - -
2 h ??? ??? ??? ???
0.5 mM 12 h - - ??? -
2 h - - ??? -
?, weak results; ??, acceptable results; ???, excellent results; -, no result; ---, excessive results
7 Filter set #20: Excitation BP 546/12, Beam Splitter FT 560,
Emission BP 575–640.
8 Filter set #09: Excitation BP 450–490, Beam Splitter FT 510,
Emission LP 515.
9 Filter set #18: Excitation BP 390–420, Beam Splitter FT 425,
Emission LP 450.
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defined as the number of linear microcracks per bone area
(Cr.Dn, #/mm2), and the diffuse damage density, defined as
the number of diffuse damage regions per bone area
(Dx.Dn, #/mm2). Length and area of damage were
expressed as mean linear crack length (Cr.Le, lm) and
diffuse damage area (Dx.Ar, lm2), whereas length and area
density were expressed as linear length density (Cr.Le.Dn,
lm/mm2) and diffuse damage area density defined as dif-
fuse damage area per bone area (Dx.Ar.Dn, %). The
reproducibility of microdamage identification was assessed
by two observers independently analyzing five sections
from five different donors. They identified 35 and 32
microcracks, respectively, 31 of which were concordant,
providing a Kappa score of 0.77. A Kappa score is always
Fig. 2 All chelating agents preserved the quality of classical
histomorphometric staining: A shows the classical histomorphometry
stain: a Goldner’s trichrome, b Solochrome cyanin R, c May-
Gru¨nwald-Giemsa, d Toluidine blue, and B shows the corresponding
stains after bulk staining by calcein green
Table 2 Two successive bulk stainings were performed on each sample (n = 16)
n Fluorochrome no. 1 Fluorochrome no. 2 Results
1 Fluorescein Basic fuchsin ---
2 Basic fuchsin Xylenol orange (water) ---
3 Calcein green (ethanol) Xylenol orange (water) ---
4 Calcein green (ethanol) Basic fuchsin ???
5 Xylenol orange (ethanol) Basic fuchsin ?
6 Xylenol orange (water) Calcein green (water) ???
7 Xylenol orange (water) Calcein green (ethanol) ???
8 Xylenol orange (ethanol) Calcein green (water) ???
9 Xylenol orange (ethanol) Calcein green (ethanol) ???
Only 9 of 16 biopsies presented interpretable microcracks. Final results on the ability to see microcracks are presented. Assays retained are
shown in italics: xylenol orange followed by calcein green (ethanol)
???, excellent results; ?, weak results; ---, excessive results
Table 3 Dilution,
concentration, wavelength and
filter used for optimum results
in microdamage detection
Agent Dilution Concentration Excitation
wavelength
Emission
wavelength
Filter
Basic fuchsin Ethanol 100% 1% 608 631 Green
Fluorescein Ringer’s solution 12% 460 515 Green
Alizarin complexone Ethanol 100% or water 0.5 mM 580 625 Red
Calcein blue Ethanol 100% or water 0.1 mM 375 435 Blue
Calcein green Ethanol 100% or water 0.5 mM 495 520 Green
Xylenol orange Ethanol 100% or water 5 mM 440, 570 610 Orange
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B1. A value of 1 implies perfect agreement and values\1
imply less than perfect agreement. In our study, a result
between 0.60 and 0.80 indicated a good agreement. The
reproducibility of linear microcrack length and diffuse
damage area measurements were assessed by two observers
on 25 microcracks and/or diffuse damage regions. The
intraclass correlation coefficients for both length and area
measurements were 0.99.
Results
Ewe bone
Two of the six fluorochromes used to evaluate the best
microcrack labeling were not satisfactory (Table 1). With
fluorescein, microcracks were visible but tetracycline
labeling (double labeling) faded and the bone area was
partly covered with fluorochrome. With calcein blue
staining, at low concentrations, double labeling (tetracy-
cline) was visible but not the microdamage whereas at high
concentrations, cracks were visible but double labeling was
faint (histomorphometry measurement unavailable). Opti-
mal results in dilution, concentration, wavelength and filter
for microdamage detection are presented in Table 3. The
classical histomorphometric stains (Goldner’s trichrome,
Solochrome cyanin R, May-Gru¨nwald-Giemsa and
Toluidine blue) were preserved after bulk staining by all
the chelating agents. Four sections stained by classical
stains after calcein green bulk staining are presented in
Fig. 2. In Goldner’s staining, osteoid still appears red-
orange and mineralized bone green appears as before bulk
staining (Fig. 2a). Solochrome cyanin R staining, which is
a reliable stain giving an unequivocal identification of
osteoid, calcified matrix and bone cells, is still valid with
the calcified bone appearing in a uniform dark blue color
and osteoid in red (Fig. 2b), and osteons are still visible in
polarized light. May-Gru¨nwald-Giemsa staining still
distinguished bone marrow cells after bulk staining in
calcein green (Fig. 2c). Toluidine blue still stained cells,
nuclei and osteoid but the calcified bone matrix remained
almost unstained (Fig. 2d). Two successive bulk stainings
were performed on the same sample combining basic
fuchsin, fluorescein, xylenol orange and calcein green
(Table 2). Several combinations of fluorochromes allowed
the detection of both the microdamage and the tetracycline.
One of the best combinations was xylenol orange followed
by calcein green (in aqueous or alcoholic solutions);
however, aqueous solutions tended to decrease the visi-
bility of previous labels (Table 1).
We also compared Cr.Le measurements after bulk
staining by the reference, basic fuchsin, followed by cal-
cein green (Table 4a) or xylenol orange (data not shown).
Assessment of the analyzed microdamage was similar in
sections stained with both basic fuchsin and calcein green
or xylenol orange. Cracks stained by basic fuchsin were
longer than those stained by calcein green. For example,
among seven microcracks from the same sample, we found
a mean difference at -2.01 lm (ranging from -0.68 to
-6.66 lm), and a relative error in the microcrack length
between -0.37 and -4.34% with a mean at -1.98%,
between the measurements (Table 4a). A highly significant
correlation was also observed between the two measure-
ments (r = 0.999, p \ 0.001). We compared the length of
the microcracks stained by calcein green with those stained
by xylenol orange in the same samples (Table 4b). On the
same sample, 8 microcracks stained by calcein green
appeared to be longer than those stained by xylenol orange.
These data showed a difference between -3.12 and
12.42 lm with a mean of ?1.55 lm, and a relative error
between -11.02 and 12.90% with a mean of ?0.95%
(Table 4b). There was no significant difference between
the lengths measured with the two fluorochromes and a
highly significant correlation was observed between the
two measurements (r = 0.967, p \ 0.001).
Our result on ewes showed that calcein green at 0.5 mM
concentration diluted in 100% ethanol as well as xylenol
orange at 5 mM were the most adequate fluorochromes to
detect both microdamage and to preserve the double tet-
racycline labeling. Examples are shown in Fig. 3. These
stains were then checked on human trabecular bone.
Human bone
In iliac trabecular bone, results were consistent with those on
ewes showing that the same cracks could be stained by several
dyes; all microcracks stained with basic fuchsin were also
observed with calcein green. Only one cross-hatched micro-
crack and one area of diffuse microcracks were observed. The
mean cancellous bone microcrack length was 120 lm.
In vertebral trabecular bone, both fluorochromes (xyle-
nol and calcein) were distinguishable using two wave-
length filters. Because all vertebrae were bulk-stained with
xylenol orange and with calcein before and after cylindrical
specimen preparation, respectively, the microdamage
stained with xylenol orange means they were present in
vivo, and those stained with calcein green were produced
from drilling and sectioning. In vivo, Cr.Dn was signifi-
cantly greater than artifactual damage (1.49 ± 1.25 vs.
0.41 ± 0.35 #/mm2; p = 0.003).
Discussion
The purpose of this study was to adapt several staining
methods developed by Norman, Schaffler, Burr, Lee, and
J Bone Miner Metab
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O’Brien et al. [2, 3, 6, 16, 17, 19, 29, 31] to our specific
aim, i.e., the detection of both microdamage and fluoro-
chrome labels (tetracycline) in human bones. Most of the
previous tests using several dyes were performed on cor-
tical bone. The novelty of our study was the use of several
fluorochromes to detect microdamage in trabecular bone
without deleting fluorochrome labels, with a large study in
ewes and validation in human bones used in clinical
practice (iliac bone).
Fluorochromes are calcium binding substances that are
preferentially taken up at the site of active mineralization of
bone, also known as the calcification front. Sun et al. [39]
found no differences between either of the non-tetracycline
labels (xylenol orange and calcein green) for any of the
histomorphometric measurements. In our study, we found
that, compared to the basic fuchsin staining, microcracks
measured by calcein green were slightly smaller in length
(mean 2 lm), but both measurements were highly corre-
lated. This could be due to the fact that fuchsin-stained
microcracks were measured under transmitted light. Lee
et al. compared fuchsin-stained microcracks in human rib
bones using transmitted light and epifluorescence micros-
copy. They found no differences between the two methods
in crack number, density or length indicating comparable
accuracy [17], suggesting that our epifluorescence
microscopy measurements could have provided similar
results. The mean difference between the microcrack length
observed with calcein green bulk staining followed by
xylenol orange was 1.55 lm in our study, without pre-
dominance of one stain on the length of the microcracks.
This difference is too small to be clinically relevant.
Comparatively, in compact bone, Lee et al. [31] found that
the length [mean (SD)] of microcracks in ten rib bones was
70.30 (46.87) lm in calcein green and 62.58 (46.45) lm in
xylenol orange without a significant difference. O’Brien
et al. provided one possible explanation about the length
difference between the two fluorochromes. They measured
the affinity of chelating agents for Ca2? ions with chro-
matography and found that the mean height of calcium peak
was higher in calcein green (0.945) than xylenol orange
(0.88). The smallest number (xylenol, 0.88) indicated a
greater affinity for calcium than calcein green [40]. Alter-
natively, as these differences were small, they may stem
from measurement variability and would therefore not be
significant.
In our study, we also found little diffuse damage in
both ewe bones and human iliac bones. This could be due
to the fact that, in both cases, the iliac bone is not a
weight-bearing bone. Moreover, [50% of human bone
biopsies had no visible trabecular bone microcracks. In
Table 4 Examples of results on
two successive bulk stainings
(same sections, same crack,
with two different filters):
quantification of microcracks
length stained in calcein green
(excitation/emission wavelength
of 495/520 nm) compared to
microcrack length stained with:
(a) 1st sample: basic fuchsin
(transmitted light), and (b) 2nd
sample: xylenol orange
(excitation/emission wavelength
of 440/610 nm)
(a) A mean difference of
*2 lm is found in the linear
microcracks length between the
two stains, but a significant
correlation is observed
(r = 0.999, p \ 0.001).
(b) A mean difference of
*1.6 lm is found in the linear
microcracks length between the
two stains but a significant
correlation is observed
(r = 0.967, p \ 0.001)
(a) Crack length
Calcein green (lm)
Crack length
Basic fuchsin (lm)
Difference (lm) Relative error (%)
n = 7
1 55.62 56.30 -0.68 -1.22
2 74.06 75.63 -1.57 -2.12
3 27.91 29.12 -1.21 -4.34
4 209.93 216.59 -6.66 -3.17
5 97.47 99.53 -2.06 -2.11
6 207.25 208.01 -0.76 -0.37
7 208.90 210.05 -1.15 -0.55
Mean 125.9 127.9 -2.01 -1.98
SD 80.2 81.1 2.1 1.43
(b) Crack length
Calcein green (lm)
Crack length
Xylenol (lm)
Difference (lm) Relative error (%)
n = 8
1 58.27 54.87 3.4 5.83
2 85.49 84.23 1.26 1.47
3 66.86 74.23 -7.37 -11.02
4 42.46 45.58 -3.12 -7.35
5 128.34 121.62 6.72 5.24
6 72.13 79.22 -7.09 -9.83
7 59.77 53.59 6.18 10.34
8 96.25 83.83 12.42 12.90
Mean 76.20 74.65 1.55 0.95
SD 27.63 25.78 7.03 8.55
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the only study comparable to ours, Stepan et al. [41]
measured transiliac crest biopsies from 38 women who
had been treated with alendronate for an average of
5 years, and compared them to a control sample of 28
women who were treatment naive. They found a differ-
ence in the mean crack length (lm) of approximately
47 lm between the treatment-naive and alendronate-
treated women. The crack length they observed was
shorter than in our study. This may be explained by false-
positive findings. Indeed, some smaller structures—like
osteocyte canaliculae—can be reminiscent of the
appearance of cracks and can be mistaken for cracks.
Microdamage was also rare in cortical bone, and only
three samples had at least one observable microcrack [36].
This may also stem from the type of bone we studied. In
animal models, it has been shown that most microcracks
are observed in long weight-bearing bones, e.g., the
femurs. In addition, the clinical significance of micro-
cracks may differ between cortical and trabecular bone
and whether the microdamage occurs under physiologi-
cal or experimental conditions. Indeed, microdamage
induced by fatigue loading impairs bone mechanical
properties, whereas pre-existing physiological micro-
damage observed in vertebrae does predict mechanical
properties [37].
It is important to remember that alcohol influences bone
mechanical properties, hence crack propagation. Therefore,
we used a combination of calcein green at 0.5 mM con-
centration and xylenol orange at 5 mM, which preserved
bone as much as possible, and also allowed the use of other
techniques to explore bone quality (data not shown:
microradiography [42], Fourier transform infrared micros-
copy [43], microhardness [44]).
In conclusion, this methodological approach allowed the
detection and the identification of both microdamage (lin-
ear, diffuse and cross-hatched)—pre-existing in vivo in
bone, or induced by the technique or mechanical loading—
and tetracycline labels as demethylchlortetracycline. Cal-
cein green at 0.5 mM concentration and xylenol orange at
5 mM seem to be the most appropriate dyes to be able to
study both microcracks and histomorphometry because
they preserve the tetracycline labels.
Fig. 3 Examples of successive
staining on ewes using several
filters: a and b microcrack
stained by basic fuchsin stays
visible after calcein green
staining using a 546/640 filter
(Filter set #20), c and d double
tetracycline label (down) and a
microcrack (upper) are visible
using a 390/450 filter (Filter set
#18) but only microdamage
(upper) remains visible after
fluorescein staining using a
450/515 filter (Filter set #09),
e and f microcrack stained in
alizarin using a 546/640 filter
(Filter set #20) is no longer
visible (right) with a 450/515
filter (Filter set #09)
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